Diversified Healthcare Trust
DHCNASDAQReal Estate● Active
$8.14
$-0.39(-4.52%)
Market Cap$2.0B
P/E Ratio—
52W High$9.14
52W Low$3.18
Diversified Healthcare Trust (DHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DHC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 4, 2026EPS Actual
-$0.14
Est. -$0.15 · +4.5%
Revenue
$0.37B
Est. $0.38B · -3.6%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 4, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 2-Quarter EPS Beat Streak
DHC reports quarterly as a NASDAQ-listed REIT - Healthcare Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | -$0.14 | — | — | — | $0.37B | — |
| ▲ Q2 FY2026 | May 4, 2026 | -$0.15 | -$0.14 | +4.5% | $0.37B | $0.38B | -3.6% |
| ▲ Q1 FY2026 | Feb 23, 2026 | -$0.15 | $0.09 | +160.0% | $0.38B | $0.39B | -3.4% |
| ▼ Q4 FY2025 | Nov 3, 2025 | $0.08 | $0.04 | -50.0% | $0.39B | $0.39B | -1.1% |
| — Q3 FY2025 | Aug 4, 2025 | $0.08 | $0.08 | +0.0% | $0.38B | $0.38B | +0.2% |
| ▲ Q2 FY2025 | May 5, 2025 | $0.04 | $0.06 | +50.0% | $0.39B | $0.38B | +1.5% |
| ▲ Q1 FY2025 | Feb 25, 2025 | -$0.29 | $0.02 | +106.9% | $0.38B | $0.37B | +2.3% |
| ▼ Q4 FY2024 | Nov 4, 2024 | $0.05 | $0.02 | -60.0% | $0.37B | $0.37B | +1.2% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
-$0.14
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 4, 2026Beat
EPS Actual
-$0.14
EPS Est.
-$0.15
EPS Surpr.
+4.5%
Revenue
$0.37B
Q1 FY2026
Feb 23, 2026Beat
EPS Actual
$0.09
EPS Est.
-$0.15
EPS Surpr.
+160.0%
Revenue
$0.38B
Q4 FY2025
Nov 3, 2025Miss
EPS Actual
$0.04
EPS Est.
$0.08
EPS Surpr.
-50.0%
Revenue
$0.39B
Q3 FY2025
Aug 4, 2025
EPS Actual
$0.08
EPS Est.
$0.08
EPS Surpr.
+0.0%
Revenue
$0.38B
Q2 FY2025
May 5, 2025Beat
EPS Actual
$0.06
EPS Est.
$0.04
EPS Surpr.
+50.0%
Revenue
$0.39B
Q1 FY2025
Feb 25, 2025Beat
EPS Actual
$0.02
EPS Est.
-$0.29
EPS Surpr.
+106.9%
Revenue
$0.38B
Q4 FY2024
Nov 4, 2024Miss
EPS Actual
$0.02
EPS Est.
$0.05
EPS Surpr.
-60.0%
Revenue
$0.37B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Q3 FY2027 | $-0.12 | $-0.12 | $-0.11 | 1 |
| Q2 FY2027 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Q1 FY2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q4 FY2026 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Q3 FY2026 | $-0.14 | $-0.14 | $-0.14 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2027 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2026 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2026 | $0.4B | $0.4B | $0.4B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 4, 2026 | +4.5% | $7.84 | $7.76 | -1.02% |
| ▲ Q1 FY2026 | Feb 23, 2026 | +160.0% | $6.24 | $6.15 | -1.44% |
| ▼ Q4 FY2025 | Nov 3, 2025 | -50.0% | $4.26 | $4.42 | +3.76% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +0.0% | $3.27 | $3.41 | +4.28% |
| ▲ Q2 FY2025 | May 5, 2025 | +50.0% | $2.27 | $2.18 | -3.96% |
| ▲ Q1 FY2025 | Feb 25, 2025 | +106.9% | $2.41 | $2.45 | +1.66% |
| ▼ Q4 FY2024 | Nov 4, 2024 | -60.0% | $3.47 | $3.52 | +1.44% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -25.0% | $3.34 | $3.29 | -1.50% |
Q2 FY2026-1.02%
Report Date
May 4, 2026
EPS Beat/Miss
+4.5%
Price Before
$7.84
Price After
$7.76
Q1 FY2026-1.44%
Report Date
Feb 23, 2026
EPS Beat/Miss
+160.0%
Price Before
$6.24
Price After
$6.15
Q4 FY2025+3.76%
Report Date
Nov 3, 2025
EPS Beat/Miss
-50.0%
Price Before
$4.26
Price After
$4.42
Q3 FY2025+4.28%
Report Date
Aug 4, 2025
EPS Beat/Miss
+0.0%
Price Before
$3.27
Price After
$3.41
Q2 FY2025-3.96%
Report Date
May 5, 2025
EPS Beat/Miss
+50.0%
Price Before
$2.27
Price After
$2.18
Q1 FY2025+1.66%
Report Date
Feb 25, 2025
EPS Beat/Miss
+106.9%
Price Before
$2.41
Price After
$2.45
Q4 FY2024+1.44%
Report Date
Nov 4, 2024
EPS Beat/Miss
-60.0%
Price Before
$3.47
Price After
$3.52
Q3 FY2024-1.50%
Report Date
Aug 1, 2024
EPS Beat/Miss
-25.0%
Price Before
$3.34
Price After
$3.29
Avg Beat Reaction-0.10%
Avg Miss Reaction+1.23%
Beat Rate5 / 8 quarters
Largest Move+4.28% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DHC ends December
Diversified Healthcare Trust (DHC) most recently reported earnings on May 4, 2026 for Q2 FY2026, posting EPS of $-0.14 — beating the analyst consensus of $-0.15 by +4.5%. DHC has beaten EPS estimates for 2 consecutive quarters. The next DHC earnings date is expected around September 1, 2026.
Each quarter, investors track DHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DHC earnings · 5 questionsDiversified Healthcare Trust's next earnings report is expected around September 1, 2026. DHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DHC historically reports after market close (AMC).
DHC earnings datewhen is DHC earningsDHC next earnings datewhen does DHC report earningsDHC earnings calendar
▸ Source: FMP · Diversified Healthcare Trust SEC filings · US GAAP · Diversified Healthcare Trust SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026